Semaglutide
Semaglutide is a GLP-1 medication that supports appetite regulation and metabolic signaling. It works by helping the body send clearer messages about fullness and blood-sugar balance.
Sustainable Weight LossAchieve lasting results with 12-15% average weight loss maintained over time
Cardiovascular ProtectionReduces risk of major cardiovascular events by 20%
Multiple Forms AvailableChoose between weekly injection or daily oral tablet for your lifestyle
Why Semaglutide is Your Weight Loss SolutionSemaglutide is a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized weight management and diabetes treatment. Originally developed for type 2 diabetes, its remarkable weight loss effects have made it the go-to choice for sustainable, medically-supervised weight management.
Patient Success Story:"After struggling with weight for years, Semaglutide finally gave me the control I needed. I've lost 38 pounds and kept it off for over a year." - Michael R.
Mechanism of Action
Diabetes Benefits:
Weight Management Success:
Clinical Excellence:The STEP clinical trial program demonstrated that 86% of patients achieved at least 5% weight loss, with many achieving transformational results of 15% or more.
Dosing and Administration
Injectable Form:Route: Subcutaneous injection once weekly
Starting Dose: 0.25 mg once weekly for 4 weeks
Dose Escalation:
Oral Form:Route: Oral tablet once daily
Starting Dose: 3 mg once daily for 30 days
Maintenance: 7 mg or 14 mg once daily
Administration: Take on empty stomach with ≤4 oz water, 30 minutes before first food/drink/medication of the day
Side Effects
Common (≥5%):
Serious (Rare):
⚖️ Semaglutide Benefits (GLP-1 Receptor Agonist)FDA-approved for type 2 diabetes and obesity treatment
1. Personal or Family History of Medullary Thyroid Carcinoma (MTC)Black box warning: GLP-1s like semaglutide are contraindicated in patients with a personal or family history of MTC or in those with Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
2. Hypersensitivity or AllergyDo not use in patients with known hypersensitivity to semaglutide or any of its components. Reactions may include anaphylaxis or angioedema.
3. History of PancreatitisSemaglutide is not recommended in patients with a history of pancreatitis due to potential risk of recurrence.
4. PregnancyContraindicated for weight loss during pregnancy. Must stop at least 2 months prior to a planned pregnancy due to long half-life and potential fetal harm.
⚠️ Use with Caution
1. Gallbladder DiseaseSemaglutide can increase the risk of cholelithiasis (gallstones) and cholecystitis, especially with rapid weight loss. Monitor for abdominal pain or signs of biliary disease.
2. Diabetic RetinopathyRapid improvement in glucose control may worsen existing retinopathy. Use caution in patients with a history of diabetic eye disease.
3. Severe GI Disorders (e.g., Gastroparesis)GLP-1s delay gastric emptying, which can worsen gastroparesis or cause significant nausea and vomiting. Avoid in patients with confirmed or suspected severe GI motility disorders.
4. Renal ImpairmentVolume depletion from nausea, vomiting, or diarrhea can worsen kidney function, especially in older adults or those with pre-existing renal disease. Hydration is key.
5. BreastfeedingNot enough data. Use only if clearly necessary and under supervision.
💉 Common Side Effects & Monitoring
Common Adverse Effects:
Labs to Monitor:
Sustainable Weight LossAchieve lasting results with 12-15% average weight loss maintained over time
Cardiovascular ProtectionReduces risk of major cardiovascular events by 20%
Multiple Forms AvailableChoose between weekly injection or daily oral tablet for your lifestyle
Why Semaglutide is Your Weight Loss SolutionSemaglutide is a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized weight management and diabetes treatment. Originally developed for type 2 diabetes, its remarkable weight loss effects have made it the go-to choice for sustainable, medically-supervised weight management.
Patient Success Story:"After struggling with weight for years, Semaglutide finally gave me the control I needed. I've lost 38 pounds and kept it off for over a year." - Michael R.
Mechanism of Action
- Insulin Secretion: Stimulates glucose-dependent insulin release from pancreatic beta cells
- Glucagon Suppression: Reduces glucagon secretion from pancreatic alpha cells when glucose levels are elevated
- Gastric Emptying: Slows gastric emptying, promoting satiety and reducing post-meal glucose spikes
- Central Appetite Control: Acts on hypothalamic receptors to reduce appetite and food intake
- Beta Cell Preservation: May help preserve pancreatic beta cell function
Diabetes Benefits:
- HbA1c reduction of 1.0-1.8%
- Reduced fasting glucose levels
- Lower postprandial glucose excursions
- Cardiovascular risk reduction
- Low hypoglycemia risk
Weight Management Success:
- Average weight loss of 12-15% in clinical trials
- Sustained weight reduction over 68 weeks
- Improved body composition
- Reduced visceral adiposity
- Better weight maintenance
Clinical Excellence:The STEP clinical trial program demonstrated that 86% of patients achieved at least 5% weight loss, with many achieving transformational results of 15% or more.
Dosing and Administration
Injectable Form:Route: Subcutaneous injection once weekly
Starting Dose: 0.25 mg once weekly for 4 weeks
Dose Escalation:
- 0.5 mg once weekly (weeks 5-8)
- 1.0 mg once weekly (maintenance for diabetes)
- 1.7 mg once weekly
- 2.4 mg once weekly (weight management dose)
Oral Form:Route: Oral tablet once daily
Starting Dose: 3 mg once daily for 30 days
Maintenance: 7 mg or 14 mg once daily
Administration: Take on empty stomach with ≤4 oz water, 30 minutes before first food/drink/medication of the day
Side Effects
Common (≥5%):
- Nausea (15-20%)
- Vomiting (5-9%)
- Diarrhea (8-9%)
- Abdominal pain (5-7%)
- Constipation (3-7%)
- Headache (5-6%)
- Fatigue (3-5%)
Serious (Rare):
- Acute pancreatitis
- Gallbladder disease
- Acute kidney injury
- Diabetic retinopathy complications
- Severe hypoglycemia (with insulin/sulfonylureas)
- Thyroid C-cell tumors (animal studies)
- Insulin and Insulin Secretagogues: Increased risk of hypoglycemia; dose reduction may be needed
- Oral Medications: May delay absorption due to delayed gastric emptying
- Warfarin: Monitor INR more frequently when initiating semaglutide
- Oral Contraceptives: Use alternative contraceptive method for 4 weeks after starting or dose increases
- Blood Glucose: Regular monitoring, especially when combined with other diabetes medications
- HbA1c: Every 3-6 months
- Weight and BMI: Regular monitoring for weight management indication
- Renal Function: Baseline and periodic monitoring
- Signs of Pancreatitis: Educate patients on symptoms
- Diabetic Retinopathy: Regular ophthalmologic examinations
⚖️ Semaglutide Benefits (GLP-1 Receptor Agonist)FDA-approved for type 2 diabetes and obesity treatment
- Appetite regulation – Acts on satiety centers in the brain
- Weight loss support – Clinical studies show significant fat loss in many users
- Blood sugar regulation – Helps control glucose levels in people with diabetes
- Reduced cravings – Anecdotal reports of diminished desire for certain foods
- Cardiometabolic support – Shown in studies to reduce cardiovascular risk in diabetics
- Delayed gastric emptying – Helps manage appetite and postprandial glucose spikes
1. Personal or Family History of Medullary Thyroid Carcinoma (MTC)Black box warning: GLP-1s like semaglutide are contraindicated in patients with a personal or family history of MTC or in those with Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
2. Hypersensitivity or AllergyDo not use in patients with known hypersensitivity to semaglutide or any of its components. Reactions may include anaphylaxis or angioedema.
3. History of PancreatitisSemaglutide is not recommended in patients with a history of pancreatitis due to potential risk of recurrence.
4. PregnancyContraindicated for weight loss during pregnancy. Must stop at least 2 months prior to a planned pregnancy due to long half-life and potential fetal harm.
⚠️ Use with Caution
1. Gallbladder DiseaseSemaglutide can increase the risk of cholelithiasis (gallstones) and cholecystitis, especially with rapid weight loss. Monitor for abdominal pain or signs of biliary disease.
2. Diabetic RetinopathyRapid improvement in glucose control may worsen existing retinopathy. Use caution in patients with a history of diabetic eye disease.
3. Severe GI Disorders (e.g., Gastroparesis)GLP-1s delay gastric emptying, which can worsen gastroparesis or cause significant nausea and vomiting. Avoid in patients with confirmed or suspected severe GI motility disorders.
4. Renal ImpairmentVolume depletion from nausea, vomiting, or diarrhea can worsen kidney function, especially in older adults or those with pre-existing renal disease. Hydration is key.
5. BreastfeedingNot enough data. Use only if clearly necessary and under supervision.
💉 Common Side Effects & Monitoring
Common Adverse Effects:
- Nausea (most common)
- Vomiting
- Diarrhea or constipation
- Decreased appetite
- Fatigue
- Dizziness
- Injection site reactions
Labs to Monitor:
- Thyroid markers (especially calcitonin)
- Renal function (BUN/Cr if at risk)
- HbA1c & fasting glucose
- Electrolytes (if persistent GI symptoms)
|
|
13 Clinton Street, North East, PA 16428
🅿️ Private off-street parking 📱 Call or Text: 716-221-6868 📧 Email: [email protected] 
HOURS
Monday-Thursday 10am-8pm Fridays 10am-6pm Saturdays 10am-2pm Sundays 10am-2pm Our last 10 minute or less service is accepted during the 10 minutes prior to closing time. Spray Tans are accepted 20 minutes prior to closing time. Spa appointments must be booked ahead of time. |
© 2019-2025 Sunny Shores Tanning & Treasures. All rights reserved. The information on this site is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Kristin Smithers, CLT "The Red Light QueenTM" is not a licensed physician. Some statements have not been evaluated by the Food and Drug Administration. Always consult your healthcare provider before beginning any new wellness or light therapy regimen.